Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Magenta Medical

Request full access

Magenta Medical has developed a temporary venous catheter-based therapy

Tel Aviv-Yafo, IsraelFounded 2012Health Tech & Medtech

About Magenta Medical

Magenta Medical develops advanced medical devices focused on providing temporary support for patients with severe heart conditions. The company specializes in two main products: the percutaneous Left Ventricular Assist Device (pLVAD) and the Transcatheter Renal Venous Decongestion System. The pLVAD is a next-generation, low-profile arterial pump designed to offer temporary support for patients undergoing high-risk coronary interventions and those suffering from cardiogenic shock. The Transcatheter Renal Venous Decongestion System is a venous pump aimed at treating hospitalized patients with acutely decompensated heart failure by reducing renal venous pressure and decompressing the kidneys.

Magenta Medical primarily serves hospitals and healthcare providers dealing with critical heart failure cases. Operating in the medical device market, the company employs a business model that includes the development, manufacturing, and sale of its specialized pumps. Revenue is generated through direct sales to healthcare institutions and partnerships with medical distributors.

Source: Dealroom company data

At a glance

Status
Operational
Employees
118
Open positions
7
Dealroom signal
54.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Cardiology and cardiovascular, Surgical Equipment, Tech for Hospitals and Clinics, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2024 $105M $420M NEA · OrbiMed · Viking Global Investors · JVC Investment Partners ↗
LATE VCOther financing May 2023 $55M $220M Pitango Venture Capital · NEA · ALIVE Israel HealthTech Fund · OrbiMed ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Magenta Medical website traffic

Latest recorded traffic for Magenta Medical is 3.2K monthly website visits, up 332.4% over the last three months. Magenta Medical's team grew 11.3% over the past year.

Latest monthly visits3.2K 3-month web change+332.4% 1-year team growth+11.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Magenta Medical in the Tel Aviv-Yafo ecosystem

Live from Dealroom

The Magenta Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A3 investors entered at this stage

  • Abiomed
  • ABIOMED, LTD.
  • Jacques R. Seguin

Series B and later7 investors entered at this stage

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Magenta Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.